Publicaciones científicas sobre los diagnósticos no invasivos de BioPredictive

Estudios revisados por pares que validan los diagnósticos por análisis de sangre de BioPredictive para enfermedades hepáticas — desde cohortes de desarrollo pioneras hasta metaanálisis a largo plazo.

13/434 Coincidencias para
“directly acting antiviral agents”

“directly acting antiviral agents” Borrar todo

  1. Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis.

    Asselah T et al. · Liver Int · 2018 Coinc. 100

    ### Background & Aims Patients with chronic hepatitis C virus infection and advanced fibrosis…

    FibroTest HCV

  2. The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. Review

    Afdhal NH et al. · J Viral Hepat · 2013 Coinc. 97

    Emerging data indicate that all-oral antiviral treatments for chronic hepatitis C…

    ActiTest FibroTest HCV

  3. HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.

    Steininger K et al. · J Viral Hepat · 2017 Coinc. 93

    …New direct-acting antiviral agent (DAA) combination therapy has not yet been…

    FibroTest HCV HIV

  4. Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.

    Preda CM et al. · Liver Int · 2018 Coinc. 89

    ### Background Direct antiviral agents (DAA) showed very good results in terms of…

    FibroTest HCV

  5. EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

    European Association for the Study of the Liver · J Hepatol · 2011 Coinc. 85

    ActiTest FibroTest HCV

  6. An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Key publication

    Myers RP et al. · Can J Gastroenterol · 2012 Coinc. 81

    …Specifically, direct-acting antiviral agents with dramatically improved rates of virological clearance…

    FibroTest HCV

  7. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies. Meta Analysis

    Poynard T et al. · Antivir Ther · 2010 Coinc. 77

    ### Background Liver biopsy and virological end points are standard references for assessing…

    ActiTest FibroTest HBV HCV +1

  8. Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection Key publication

    · 2014 Coinc. 74

    These are the first guidelines dealing with hepatitis C treatment produced by…

    FibroTest HCV

  9. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

    Terrault NA et al. · Hepatology · 2018 Coinc. 70

    ActiTest FibroTest HBV

  10. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection

    · 2015 Coinc. 66

    These are the first World Health Organization (WHO) guidelines for the prevention…

    FibroTest HBV

  11. Ministère des Affaires Sociales et de la Santé Key publication

    Coinc. 62

    FibroTest HBV HCV

  12. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. Key publication

    European Association for Study of Liver et al. · J Hepatol · 2015 Coinc. 58

    FibroTest Alcohol HBV HCV +3

  13. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.

    Stevenson M et al. · Health Technol Assess · 2012 Coinc. 54

    ### Background Excessive alcohol consumption may lead to the development of alcohol-related…

    FibroTest Alcohol

Mostrando la lista completa de resultados. La página se renderiza en el servidor y no está paginada.